Asset Allocation Financial Services Pharmaceutical Valuation 
Brown Advisory
NOVEMBER 12, 2019
Equity returns are less predictable, but we believe they are more likely than not to be lower going forward compared to the post-crisis period, given the outlook for modest GDP growth around the world alongside today’s elevated valuations. A core allocation to high-grade bonds can play a similar role.
Brown Advisory
NOVEMBER 12, 2019
Equity returns are less predictable, but we believe they are more likely than not to be lower going forward compared to the post-crisis period, given the outlook for modest GDP growth around the world alongside today’s elevated valuations. A core allocation to high-grade bonds can play a similar role.
Expert insights. Personalized for you.
52 
Let's personalize your content